Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

HASH(0x55d844687060) ; HASH(0x55d844588fe0)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Publication Date:
      2022
    • Collection:
      Ludwig Boltzmann Institute of Health Technology Assessment (LBI-HTA): Repository
    • File Description:
      application/pdf
    • Relation:
      https://eprints.aihta.at/1356/1/Oncology%20Fact%20Sheet%20Nr.75_Update.pdf; Wolf, S. (2022): Lorlatinib (Lorviqua®) as monotherapy for the treatment of anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC). Update March 2022. Oncology Fact Sheet Nr. 75.
    • Online Access:
      https://eprints.aihta.at/1356/
      https://eprints.aihta.at/1356/1/Oncology%20Fact%20Sheet%20Nr.75_Update.pdf
    • Rights:
      cc_by
    • Accession Number:
      edsbas.E9C162EC